ENDGAME, INC. AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2019 (UNAUDITED) AND DECEMBER 31, 2018 AND
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018 (UNAUDITED)
Note 6—Debt
Term Loans– On September 16, 2015, the Company entered into a36-month term loan with a commercial bank (the “Lender”) totaling $3,000,000 and bearing interest at a rate equal to 1.75% above the prime rate payable monthly beginning in October 2015 (the “Bridge Bank Loan”). The proceeds were used to pay off the remaining outstanding balance of a previous term loan obtained in January 2013.
On June 1, 2017, the Company amended the Bridge Bank Loan to increase the credit facility from $3,000,000 to $7,000,000. The amended loan bears interest at a rate equal to 1.50% above the prime rate. (6.50% and 7.00% at September 30, 2019 and December 31, 2018, respectively). The $3,000,000 first tranche of the term loan is payable in 30 equal installments of principal, plus all accrued and unpaid interest beginning in January 2019.
On March 15, 2018, the Company drew the Second Tranche of the Bridge Bank Loan in the amount of $4,000,000. The Second Tranche Term II Loan is payable in 36 equal monthly installments of principal plus all accrued and unpaid interest beginning March 2019. The proceeds were used by the Company to fund operations. The obligations of the Company under the Term Loan Agreement and the other term loan documents are secured by liens on and security interests in substantially all of the assets of the Company.
Revolving Line of Credit– In conjunction with the36-month term loan with the Lender on September 16, 2015, the Company obtained a revolving line credit extension of up to $8,000,000. This revolving credit extension was increased to $15,000,000 on August 16, 2018, and bears interest at a rate equal to 0.50% above the prime rate (5.5% and 6.00% at September 30, 2019 and December 31, 2018, respectively). The Company may request advances in an amount that may not exceed at any time contractual monthly recurring revenue for the trailing five months multiplied by the monthly retention rate (monthly recurring revenue for the trailing five months divided by monthly recurring revenue for the trailing 12 months) less the principal amount of any outstanding advances. Therefore, credit available under the revolving line of credit may be less than the specified amount. The maturity date of this revolver is on June 1, 2021. On June 28, 2019, the line of credit agreement with the Lender was amended to expand the line of credit limit by adjusting the borrowing availability calculation basis from five-month trailing Monthly Recurring Revenue (“MRR”) to nine-month trailing MRR through September 30, 2019, after which, the borrowing availability calculation will revert to five-month trailing MRR. The amendment includes a fee to be paid to the Lender, instead of warrants, in the amount of $300,000 if the Company is sold to a strategic or financial investor. The fee in lieu of warrants has not been accrued for as of September 30, 2019 due to the events that would trigger the amounts being owed to the Lender not yet occurring. The outstanding balance on the revolving line of credit as of September 30, 2019, and December 31, 2018 was $14,500,000 and $7,000,000, respectively. The total availability on the revolving line of credit as of September 30, 2019 and December 31, 2018 was approximately $500,000 and $1,548,000, respectively.
Convertible Notes Payable– On April 30, 2019, the Company entered into a note and common stock purchase agreement to sell convertible notes and common stock in an amount not to exceed $8,000,000. The Company received approximately $3,634,533 through the issuance of convertible notes and 441,341 shares of common stock. The convertible notes payable accrue interest at 6% per annum. The principal, together with all accrued and unpaid interest, is due and payable in full upon request of the holders of a majority of the outstanding principal amount of the convertible notes (“Majority Holders”) on or after the maturity date which is 12 months from the date the convertible notes were issued. The Company may not prepay the convertible notes prior to the maturity date without the consent of the Majority Holders.
13